Zynerba Pharmaceuticals Inc (ZYNE) Stock Has Fallen -1.56% This Week: Buy, Hold, or Sell?

Tuesday, October 03, 2023 11:54 AM | InvestorsObserver Analysts

Mentioned in this article

Zynerba Pharmaceuticals Inc (ZYNE) Stock Has Fallen -1.56% This Week: Buy, Hold, or Sell?

Zynerba Pharmaceuticals Inc (ZYNE) stock is higher by 61.54% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ZYNE stock a score of 61 out of a possible 100.

That rank is influenced by a long-term technical score of 100. ZYNE's rank also includes a short-term technical score of 80.

ZYNE has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on ZYNE!

See Full ZYNE Report

What's Happening with ZYNE Stock Today

Zynerba Pharmaceuticals Inc (ZYNE) stock is flat -0.39% while the S&P 500 is lower by -1.49% as of 11:53 AM on Tuesday, Oct 3. ZYNE is flat $0.00 from the previous closing price of $1.27 on volume of 326,713 shares. Over the past year the S&P 500 has risen 14.85% while ZYNE is higher by 61.54%. ZYNE lost -$0.80 per share in the over the last 12 months. Click Here to get the full Stock Report for Zynerba Pharmaceuticals Inc stock.